ConductScience.org, home

Trial · NCT07913451

Registered outcomes31

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
SecondaryQuantified Vestibular Ocular Motor Screen (qVOMS)Day 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)
Test that evaluates both symptom reproduction (headache, dizziness, nausea, fogginess) and clinical performance on 7 tests that include both eye and head motion. normal/abnormal for clinical performance and 0-10 for symptoms where a lower number for symptoms is a better score.
SecondaryAccommodationDay 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)Maximal point at which the participant can see clearly as a target moves toward the face, measured for right and left eye separately, cm and a lower score is a better score
SecondaryFrisby testDay 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)Ability to see depth, yes/no
SecondaryAdvanced Functional Gait AssessmentDay 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)Dynamic balance test that includes 16 different tests with higher scores representing better performance 0-48 and a higher score is a better performance
Secondarywalking while talking testDay 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)20 foot walking test that evaluates the ability to divide attention while walking, outcome is measured in seconds to complete the task. measured in seconds, a lower score is a better score
Secondarytimed dual task tandem gaitDay 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)Heel to toe gait with a cognitive task. seconds and a lower score is a better score
SecondaryOttawa Mental Skills Assessment Tool-3Day 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)
12 mental skills measure: goal setting, self-confidence, commitment, stress reactions, relaxation, fear control, activation, focusing, imagery, competition planning, mental practice, and refocusing; each item scored on a scale from 1 totally disagree to 7 totally agree; mean score per scale for each individual skill.
SecondarySport Mental Health Assessment Tool (SMHAT)Day 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)Tool that screens for mental health conditions in athletes; multistage screening using a step by step process to evaluate specific mental health domains.
SecondaryPatient Health Questionnaire (PHQ9)Day 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)Patient Health Questionnaire - 9 to screen for depression, 0-27 with higher scores representing greater depression severity
SecondaryGeneralized Anxiety Disorder 7 (GAD7)Day 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)Self report measure for generalized anxiety disorder; scored from 0-21 with over 10 is typically a clinical cutoff suggesting probably Generalized anxiety disorder
SecondaryThe Transition-Agility SkateDay 1, 6 weeks, 12 weeks, end of season (approximately 24 weeks)
The Transition-Agility Skate course will be set up using four pylons arranged in a square measuring 24 ft × 24 ft (7.32 m × 7.32 m), measured from the centre of each pylon base. The start/finish line will be positioned 12 feet (3.65 m) from the centre of horizontal line between the 2 nearest cones. , and the designated stop line will be positioned on the opposite side of the course, as shown in Figure 2. Pylon locations, the start/finish line, and the stop line will be measured before testing and marked on the ice using spray paint or tape to ensure consistent placement across athletes and trials. If a pylon is displaced, it will be returned to the marked location before the next trial. Measured in seconds, a shorter score is considered to be a better score.

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07913451/registered?page=2